SynthesisJournal of neuro-oncology2025
Intra-cavitary radiotherapy for surgically resected brain metastases: a comprehensive analysis including an individual patient data meta-analysis of intraoperative radiotherapy (IORT) and brachytherapy (IBT).
Synthesis in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurgical resection followed by adjuvant radiotherapy is a standard approach for brain metastases (BM). Intracavitary radiotherapy techniques-namely intraoperative radiotherapy (IORT) and brachytherapy (IBT)-have gained attention as alternatives to stereotactic radiotherapy, potentially reducing neurotoxicity and treatment delays. However, robust comparative data remain scarce.
methodsWe performed a systematic meta-analysis including both conventional and reconstructed individual patient data (IPD) from studies reporting outcomes after intracavitary radiotherapy post-BM resection. Primary endpoint was local control rate (LCR); secondary endpoints included overall survival (OS), distant brain control (DBC), radiation necrosis (RN), and leptomeningeal disease (LMD). IPD was reconstructed from published Kaplan-Meier curves. Survival and incidence outcomes were pooled using random-effects models in R.
resultsTwenty-three studies with 858 patients were analyzed. The 1-year LCR was 96% (95% CI: 94-98%) for IORT and 95% (95% CI: 92-97%) for IBT. Median OS in patients who underwent IORT was 39.1 months (95% CI: 22.0-59.5), and 15.9 months (95% CI: 12.6-19.9) in whose who underwent IBT, respectively (p = 0.004; HR 0.64). IORT was associated with lower RN (4% vs. 7%) and LMD (6% vs. 9%). The 1-year DBC rate was higher for IORT (57%) than IBT (48%).
conclusionsIntracavitary radiotherapy yields excellent local control after BM resection. This IPD meta-analysis provides the most comprehensive evidence to date and supports further prospective evaluation of IORT in neuro-oncological care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.